journal article·2024-03

Minimally invasive delivery of human umbilical cord-derived mesenchymal stem cells by an injectable hydrogel via Diels–Alder click reaction for the treatment of intrauterine adhesions

Sentao Hu, Yangyang Dai, Liaobing Xin, Xiaowen Zheng, Zi Ye, Songying Zhang, Lie Ma

Acta Biomaterialia· Volume 177
Publisher page

Abstract

Intrauterine adhesions (IUA) are the most common cause of uterine infertility, and conventional treatments have not consistently achieved satisfactory pregnancy rates. Stem cell therapy shows promising potential for the clinical treatment of IUA. Although various advanced biomaterials have been designed for delivering stem cells to the uterine cavity, there remain significant challenges, particularly in devising therapeutic strategies for clinical application that minimize surgical incisions and conform to the intricate structure of uterine cavity. Herein, an injectable hydrogel loaded with human umbilical cord-derived mesenchymal stem cells (UCMSCs) was synthesized via the Diels-Alder click reaction for endometrial regeneration and fertility restoration, exhibiting suitable mechanical properties, good biocompatibility, and desirable degradation properties. Notably, this hydrogel permitted minimally invasive administration and integrated seamlessly with surrounding tissue. Our study revealed that the UCMSCs-laden injectable hydrogel enhanced cell proliferation, migration, angiogenesis, and exhibited anti-fibrotic effects in vitro. The implantation of this hydrogel significantly facilitated endometrium regeneration and restored fertility in a rat endometrial damage model. Mechanistically, in vivo results indicated that the UCMSCs-laden injectable hydrogel effectively promoted macrophage recruitment and facilitated M2 phenotype polarization. Collectively, this hydrogel demonstrated efficacy in regenerating damaged endometrium, leading to the restoration of fertility. Consequently, it holds promise as a potential therapeutic strategy for endometrial damage and fertility decline arising from intrauterine adhesions. STATEMENT OF SIGNIFICANCE: Severe endometrial traumas frequently lead to intrauterine adhesions and subsequent infertility. Stem cell therapy shows promising potential for the clinical treatment of IUA; however, challenges remain, including low delivery efficiency and compromised stem cell activity during the delivery process. In this study, we fabricated an injectable hydrogel loaded with UCMSCs via the Diels-Alder click reaction, which exhibited unique bioorthogonality. The in situ-gelling hydrogels could be introduced through a minimally invasive procedure and adapt to the intricate anatomy of the uterus. The UCMSCs-laden injectable hydrogel promoted endometrial regeneration and fertility restoration in a rat endometrial damage model, efficaciously augmenting macrophage recruitment and promoting their polarization to the M2 phenotype. The administration of UCMSCs-laden injectable hydrogel presents a promising therapeutic strategy for patients with severe intrauterine adhesion.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Gynecological conditions and treatments · Tissue Engineering and Regenerative Medicine · Uterine Myomas and Treatments

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (41)

Show source-provided references
1. Strategies for modelling endometrial diseases10.1038/s41574-022-00725-z ↗
2. The management of Asherman syndrome: a review of literature10.1186/1477-7827-11-118 ↗
3. Asherman's syndrome: current perspectives on diagnosis and management10.2147/IJWH.S165474 ↗
4. A comparison of intrauterine balloon, intrauterine contraceptive device and hyaluronic acid gel in the prevention of adhesion reformation following hysteroscopic surgery for Asherman syndrome: a cohort study10.1016/j.ejogrb.2013.07.018 ↗
5. A comprehensive review of Asherman's syndrome: causes, symptoms and treatment options10.1097/GCO.0000000000000378 ↗
6. Prevalence of intrauterine adhesions after the application of hyaluronic acid gel after dilatation and curettage in women with at least one previous curettage: short-term outcomes of a multicenter, prospective randomized controlled trial10.1016/j.fertnstert.2017.02.113 ↗
7. Cell-based therapy in thin endometrium and Asherman syndrome10.1186/s13287-021-02698-8 ↗
8. Stem cell-based therapy for ameliorating intrauterine adhesion and endometrium injury10.1186/s13287-021-02620-2 ↗
9. The latest developments in immunomodulation of mesenchymal stem cells in the treatment of intrauterine adhesions
10. Autologous cell therapy with CD133+ bone marrow-derived stem cells for refractory Asherman's syndrome and endometrial atrophy: a pilot cohort study10.1093/humrep/dew042 ↗
11. Stem cell therapy in Asherman syndrome and thin endometrium: stem cell- based therapy10.1016/j.biopha.2018.03.091 ↗
12. Allogeneic cell therapy using umbilical cord MSCs on collagen scaffolds for patients with recurrent uterine adhesion: a phase I clinical trial10.1186/s13287-018-0904-3 ↗
13. In situ delivery of apoptotic bodies derived from mesenchymal stem cells via a hyaluronic acid hydrogel: a therapy for intrauterine adhesions
14. Reconstructable uterus-derived materials for uterus recovery toward efficient live births10.1002/adma.202106510 ↗
15. A scaffold laden with mesenchymal stem cell-derived exosomes for promoting endometrium regeneration and fertility restoration through macrophage immunomodulation10.1016/j.actbio.2020.06.029 ↗
16. A construct of adipose-derived mesenchymal stem cells-laden collagen scaffold for fertility restoration by inhibiting fibrosis in a rat model of endometrial injury10.1093/rb/rbad080 ↗
17. Functionalized human umbilical cord mesenchymal stem cells and injectable HA/Gel hydrogel synergy in endometrial repair and fertility recovery10.1016/j.actbio.2023.06.013 ↗
18. Injectable 3D-Printed porous Scaffolds for adipose stem cell delivery and endometrial regeneration10.1002/adfm.202303368 ↗
19. A collagen scaffold loaded with human umbilical cord-derived mesenchymal stem cells facilitates endometrial regeneration and restores fertility10.1016/j.actbio.2019.05.012 ↗
20. Advances in biodegradable and injectable hydrogels for biomedical applications10.1016/j.jconrel.2020.12.008 ↗
21. In situ forming injectable hydrogels for drug delivery and wound repair10.1016/j.addr.2018.03.007 ↗
22. Translational applications of hydrogels10.1021/acs.chemrev.0c01177 ↗
23. Injectable hydrogels: an emerging therapeutic strategy for cartilage regeneration10.1016/j.cis.2023.103030 ↗
24. Crosslinkers for polysaccharides and proteins: synthesis conditions, mechanisms, and crosslinking efficiency, a review10.1016/j.ijbiomac.2022.01.029 ↗
25. Chemical reactions in living systems
26. Designing hydrogels for 3D cell culture using dynamic covalent crosslinking10.1002/adhm.202100234 ↗
27. Click hydrogels, microgels and nanogels: emerging platforms for drug delivery and tissue engineering10.1016/j.biomaterials.2014.03.001 ↗
28. 3D extracellular matrix mimics: fundamental concepts and role of materials chemistry to influence stem cell fate10.1021/acs.biomac.0c00045 ↗
29. Click chemistry hydrogels for extrusion bioprinting: progress, challenges, and opportunities10.1021/acs.biomac.1c01105 ↗
30. Diels–Alder click-cross-linked hydrogels with increased reactivity enable 3D cell encapsulation10.1021/acs.biomac.7b01715 ↗
31. si-SNHG5-FOXF2 inhibits TGF-β1-induced fibrosis in human primary endometrial stromal cells by the Wnt/β-catenin signalling pathway10.1186/s13287-020-01990-3 ↗
32. Tissue stiffness at the human maternal–fetal interface10.1093/humrep/dez139 ↗
33. Exosomes derived from mesenchymal stem cells reverse EMT via TGF-β1/Smad pathway and promote repair of damaged endometrium10.1186/s13287-019-1332-8 ↗
34. New insights into TGF-β/Smad signaling in tissue fibrosis10.1016/j.cbi.2018.07.008 ↗
35. Specificity, versatility, and control of TGF-β family signaling10.1126/scisignal.aav5183 ↗
36. Metformin reverses established lung fibrosis in a bleomycin model10.1038/s41591-018-0087-6 ↗
37. Macrophage phenotypes in tissue repair and the foreign body response: implications for biomaterial-based regenerative medicine strategies10.1016/j.actbio.2021.03.038 ↗
38. Macroscale biomaterials strategies for local immunomodulation10.1038/s41578-019-0106-3 ↗
39. Effects of mesenchymal stem cell-derived paracrine signals and their delivery strategies10.1002/adhm.202001689 ↗
40. Hopes and limits of adipose-derived stem cells (ADSCs) and mesenchymal stem cells (MSCs) in wound healing10.3390/ijms21041306 ↗
41. Biomimetic immunomodulation strategies for effective tissue repair and restoration10.1016/j.addr.2021.113913 ↗